Equities

Trinity Biotech PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Trinity Biotech PLC

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.8204
  • Today's Change-0.050 / -5.70%
  • Shares traded130.32k
  • 1 Year change+8.66%
  • Beta0.5944
Data delayed at least 15 minutes, as of Feb 11 2026 18:28 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.

  • Revenue in USD (TTM)49.41m
  • Net income in USD-35.91m
  • Incorporated1992
  • Employees401.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PAVmed Inc29.00k-595.00k10.91m39.0029.6229.89--376.29-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
SINTX Technologies Inc1.27m-16.56m11.09m20.00--2.56--8.74-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
Envoy Medical Inc208.00k-28.61m11.22m42.00------53.96-1.44-1.440.0103-0.32180.02370.501.794,952.38-247.90-------294.23---10,475.00--0.4582-14.86-----28.80--10.55------
Movano Inc500.00k-17.05m11.29m32.00------22.57-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
QHSLab Inc2.61m-386.75k11.39m4.00------4.36-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
REMSleep Holdings Inc12.27k-3.01m11.65m6.00--48.29--949.24-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
BioNano Genomics Inc28.72m-38.59m11.91m98.00--0.2286--0.4146-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
BioRegenx Inc1.93m-18.93m12.50m5.00------6.48-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
Vicarious Surgical Inc0.00-53.59m14.16m123.00--0.8418-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
United Health Products Inc0.00-2.95m14.98m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Trinity Biotech PLC (ADR)49.41m-35.91m16.07m401.00------0.3252-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Vivos Therapeutics Inc17.32m-17.10m16.14m109.00--5.58--0.932-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
Retractable Technologies Inc37.90m-6.68m19.76m221.00--0.258123.770.5213-0.223-0.2231.272.560.24921.864.43171,495.80-4.248.45-4.509.59-2.4238.19-17.0115.054.54--0.0126---24.19-4.59-67.29--17.90--
Milestone Scientific Inc8.93m-6.67m20.21m17.00--7.92--2.26-0.0823-0.08230.10990.03250.90840.489614.06525,265.90-67.82-48.29-122.68-62.1471.8665.25-74.66-81.560.5103-837.640.2518---12.190.602731.97--0.40--
Adagio Medical Holdings Inc137.00k-79.15m21.39m86.00------156.14-4.75-4.750.0087-0.08530.0020.75583.041,593.02-114.09---130.69---1,468.61---57,771.53--0.6798-4.931.07--100.67---105.09------
Jin Medical International Ltd22.83m1.79m21.92m269.0012.230.785211.110.96010.01150.01150.14580.17830.5093.264.1584,857.363.8510.686.3416.5135.7934.537.5513.921.90--0.36170.0018.572.9027.710.155496.27--
Data as of Feb 11 2026. Currency figures normalised to Trinity Biotech PLC's reporting currency: US Dollar USD

Institutional shareholders

5.23%Per cent of shares held by top holders
HolderShares% Held
Hunter Associates Investment Management LLCas of 31 Dec 2025526.61k2.83%
Renaissance Technologies LLCas of 30 Sep 2025171.36k0.92%
Williams & Novak LLCas of 31 Dec 202593.30k0.50%
Citadel Securities LLCas of 30 Sep 202539.38k0.21%
CapFinancial Partners LLCas of 30 Sep 202527.25k0.15%
Moss Adams Wealth Advisors LLCas of 31 Dec 202525.67k0.14%
Inspirion Wealth Advisors LLCas of 31 Dec 202525.00k0.13%
Two Sigma Investments LPas of 30 Sep 202523.99k0.13%
Cambridge Investment Research Advisors, Inc.as of 31 Dec 202522.28k0.12%
Raymond James & Associates, Inc. (Invt Mgmt)as of 30 Sep 202520.32k0.11%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.